ABSTRACr Norharman enhanced the known mutagenicity of 2-acetylaminofluorene derivatives in the Salmonella test system. The mutagenicities of 2-acetylaminofluorene, 2-aminofluorene, and N-hydroxy-2-acetylaminofluorene were enhanced by norharman only when rat liver microsomal enzymes were added, whereas the mutagenicity of N-acetoxy--acetylaminofluorene was increased in the absence of microsomal enzymes. Harman also increased mutagenesis, although less so than norharman.
Two highly mutagenic compounds isolated from tryptophan pyrolysate have been found to be -y-carbolinies (1) . Their mutagenicities in the Salmonella test system were greatly increased by norharman and harman, which were also found in tryptophan pyrolysate (2) . Because norharman and harman themselves have no mutagenic activity, they were called "comutagens." Later it was reported that norharman enhanced the mutagenicity of benzo[a]pyrene and dimethylaminoazobenzene and that aniline or o-toluidine, either of which alone is nonmutagenic, became mutagenic under the comutagenic action of norharman (2, 3) . All the mutagens so far found to be activated by norharman required metabolic activation by S-9 mix.
2-Acetylaminofluorene and many of its derivatives are both potent mutagens and carcinogens (4) . Among these compounds, 2-acetylaminofluorene(AAF) and 2-aminofluorene(AF) require metabolic activation for mutagenesis, but N-hydroxy-AAF and N-acetoxy-AAF can induce mutagenesis without metabolic activation (5) . This paper reports that the mutagenicities of AAF derivatives were enhanced by norharman and harman in the mutation test using his-Salmonella typhimurium and considers the mechanism of the comutagenic effect.
MATERIALS AND METHODS
Chemicals. AAF, N-hydroxy-AAF, and N-acetoxy-AAF were supplied by E. K. Weisburger (6) . Mutagens were dissolved in 0.025 ml of dimethyl sulfoxide and added to 0.5 ml of S-9 mix (S-9 mix was prepared from the post-mitochondrial supernatant of the liver of rats that had been pretreated with polychlorinated biphenyl; our S-9 mix contained 4 ,gmol of NADH and NADPH per ml but no NADP) or 0.2 M sodium phosphate buffer (pH 7.4) with 0.1 ml of bacterial suspension. Norharman and harman were dissolved in 0.02 ml of dimethyl sulfoxide and added at the same time as the mutagens. The mixtures were incubated for 30 min at 30°with shaking. Then they were rapidly mixed with 2 ml of molten soft agar containing 0.1 Mmol of L-histidine and biotin, poured onto minimal glucose agar plates, and incubated for 2 days at 370.
RESULTS
In the presence of S-9 mix for metabolic activation, 0.02 ,umol of AAF reverted approximately 1000 colonies from a lawn of 108 S. typhimurium TA98 organisms in our test system. Addition of 1 ,mol of norharman enhanced this mutagenesis about 6-fold (Fig. 1A) . Harman increased the mutagenicity of AAF about 3fold. Similarly, 0.02 jmol of AF reverted approximately 1000 colonies with S-9 mix, and norharman and harman showed comutagenic effects with AF (Fig. 1B) .
The dose-response curves from the effect of norharman and harman on the mutagenesis induced by 0.01 ,mol of AAF are shown in Fig. 2 . Norharman was most effective when added at a dose of 1.5 umol per preincubation tube. Because the volume of the preincubation mixture was 0.645 ml, this represents a concentration of about 2.3 mM. The maximal effect of harman was observed with a dose of 1 ,umol, or a concentration of 1.5 mM in the preincubation mixture. N-Hydroxy-AAF is known to be one of the metabolites of AAF formed by microsomal enzymes. Without S-9 mix, 0.16 ,umol of N-hydroxy-AAF reverted only about 200 colonies, and the effect was not enhanced by norharman or harman (Fig. 3A) . In the presence of S-9 mix, however, N-hydroxy-AAF was a stronger mutagen and its mutagenicity was greatly increased by norharman and harman (Fig. 3B) .
N-Acetoxy-AAF is thought to be one of the ultimate mutagenic forms of AAF after metabolic activation. Without S-9 mix, 0.02 gmol of N-acetoxy-AAF reverted about 1800 colonies.
As shown in Fig. 4A , its mutagenicity was increased about 7-fold by norharman and 2.5-fold by harman. In the presence of 5-9 mix, the mutagenicity of N-acetoxy-AAF was slightly weaker, and norharman and harman enhanced the mutagenicity slightly less than without S-9 mix (Fig. 4B) .
Addition of norharman at 1 ,umol per plate did not enhance Abbreviations: AAF, 2-acetylaminofluorene; AF, 2-aminofluorene.
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AAF is also a strong mutagen in bacterial test systems (5, 12). For mutagenesis, AAF and AF require metabolic activation by S-9 mix, and therefore they are called promutagens. N-hydroxy-AAF, a proximate mutagen, is weakly mutagenic itself, but its mutagenicity is enhanced by metabolic activation. On the other hand, N-acetoxy-AAF is an ultimate mutagen, possessing full mutagenic activity without metabolic activation. We have shown that, although S-9 mix is required for the comutagenic action of norharman on the promutagen and the a) proximate mutagen, it is not required when the ultimate mutagen, N-acetoxy-AAF, is used. Three possible mechanisms for the comutagenic effect may be considered: alteration of the extracellular metabolic activation of mutagens, alteration of the bacterial metabolism involved in mutagenesis, and a more direct action such as interaction of comutagens with DNA. Our findings support the idea that the comutagenic effect is not solely dependent on alteration of the metabolic activation.
Both norharman and harman have strong fluorescence with peaks at 450 nm. It was reported (13) that quenching of fluorescence was observed when DNA was added to solutions of norharman, indicating that it interacted with norharman. The comutagens might interact with DNA, altering the conformation of the polynucleotide and increasing the affinity to mutagens. It has been shown that daunorubicin and adriamycin, which intercalate but do not covalently bind to DNA, fa- 
